DRTF is very pleased to announce the following grant awards. Your support is allowing us to fund these innovative projects!
2016 Grants
Mushriq Al-Jazrawe, HBSc, PhD candidate, The Hospital for Sick Children, Toronto, Canada.
"Single cell-derived clonal analysis of desmoid tumors to investigate tumor-stroma interactions."
Kelly Mercier, PhD, RTI International.
"A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates."
Raphael Pollock, MD, PhD, The Ohio State University.
"Reactivating of apoptosis: a potential therapeutic target for desmoid tumors with CTNNB1 S45F mutation."
Kris Vleminckx, PhD, Ghent University, Belgium.
"Identifying targets for therapy in a novel genetic Xenopus model for desmoid tumor formation."
Breelyn Wilky, MD, Sylvester Comprehensive Cancer Center, University of Miami.
"Correlation of CTNNB1 Mutation Status with Chemotherapy Response by MRI in Patients with Desmoid Tumors."
2015 Grants (funded December 2015)
Benjamin Alman, MD, Duke University.
"Collaboration for a Cure: Identifying new therapeutic targets for desmoid tumors."
Mrinal Gounder, MD, Memorial Sloan Kettering Cancer Center
"Development of a Patient Reported Outcome (PRO) tool in desmoid tumors."
Matt van de Rijn, MD, PhD, Stanford University. "Next generation sequencing approach to desmoid tumors."
Read the scientific and lay abstracts for these projects here.
